Literature DB >> 24246643

Sensitive in vivo cell detection using size-optimized superparamagnetic nanoparticles.

Jesse Trekker1, Cindy Leten2, Tom Struys3, Vera V Lazenka4, Barbara Argibay5, Liesbeth Micholt6, Ivo Lambrichts7, Willem Van Roy6, Liesbet Lagae8, Uwe Himmelreich2.   

Abstract

Magnetic nanoparticle (MNP) enabled cell visualization with magnetic resonance imaging (MRI) is currently an intensively studied area of research. In the present study, we have synthesized polyethylene glycolated (PEG) MNPs and validated their suitability as MR cell labeling agents in in vitro and in vivo experiments. The labeling of therapeutic potent mesenchymal stem cells (MSCs) with small core and large core MNPs was evaluated. Both MNPs were, in combination with a transfection agent, stably internalized into the MSCs and didn't show an effect on cell metabolism. The labeled cells showed high contrast in MRI phantom studies. For quantification purposes, the MRI contrast generating properties of cells labeled with small core MNPs were compared with large core MNPs and with the commercial contrast agent Endorem. MSCs labeled with the large core MNPs showed the highest contrast generating properties in in vitro phantom studies and in in vivo intracranial stereotactic injection experiments, confirming the size-relaxivity relationship in biological systems. Finally, the distribution of MSCs pre-labeled with large core PEGylated MNPs was visualized non-invasively with MRI in a glioma model.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell labeling; Cell tracking; MRI; Magnetic nanoparticle; Mesenchymal stem cells

Mesh:

Year:  2013        PMID: 24246643     DOI: 10.1016/j.biomaterials.2013.11.006

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  Label-Free Iron Oxide Nanoparticles as Multimodal Contrast Agents in Cells Using Multi-Photon and Magnetic Resonance Imaging.

Authors:  Hendrik Reynders; Indra Van Zundert; Rui Silva; Bram Carlier; Olivier Deschaume; Carmen Bartic; Susana Rocha; Sergey Basov; Margriet J Van Bael; Uwe Himmelreich; Thierry Verbiest; Ana Zamora
Journal:  Int J Nanomedicine       Date:  2021-12-30

2.  Fluorine MR Imaging Probes Dynamic Migratory Profiles of Perfluorocarbon-Loaded Dendritic Cells After Streptozotocin-Induced Inflammation.

Authors:  Shweta Saini; An-Sofie Vanherwegen; Sayuan Liang; Rein Verbeke; Hannelie Korf; Ine Lentacker; Stefaan C De Smedt; Conny Gysemans; Uwe Himmelreich
Journal:  Mol Imaging Biol       Date:  2022-01-20       Impact factor: 3.488

Review 3.  Nanoparticles and clinically applicable cell tracking.

Authors:  Monique R Bernsen; Jamal Guenoun; Sandra T van Tiel; Gabriel P Krestin
Journal:  Br J Radiol       Date:  2015-08-07       Impact factor: 3.629

4.  Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging.

Authors:  Antoine D'Hollander; Evelien Mathieu; Hilde Jans; Greetje Vande Velde; Tim Stakenborg; Pol Van Dorpe; Uwe Himmelreich; Liesbet Lagae
Journal:  Int J Nanomedicine       Date:  2016-08-04

5.  Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia.

Authors:  Bárbara Argibay; Jesse Trekker; Uwe Himmelreich; Andrés Beiras; Antonio Topete; Pablo Taboada; María Pérez-Mato; Alba Vieites-Prado; Ramón Iglesias-Rey; José Rivas; Anna M Planas; Tomás Sobrino; José Castillo; Francisco Campos
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

6.  Improved Labeling of Pancreatic Islets Using Cationic Magnetoliposomes.

Authors:  Rita Sofia Garcia Ribeiro; Ashwini Ketkar-Atre; Ting Yin; Karim Louchami; Tom Struys; Ivo Lambrichts; Abdullah Sener; Willy Jean Malaisse; Marcel De Cuyper; Uwe Himmelreich
Journal:  J Pers Med       Date:  2018-03-12

7.  The effect of adipose tissue-derived stem cells in a middle cerebral artery occlusion stroke model depends on their engraftment rate.

Authors:  Saskia Grudzenski; Sebastian Baier; Anne Ebert; Pim Pullens; Andreas Lemke; Karen Bieback; Rick M Dijkhuizen; Lothar R Schad; Angelika Alonso; Michael G Hennerici; Marc Fatar
Journal:  Stem Cell Res Ther       Date:  2017-04-26       Impact factor: 6.832

8.  Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes.

Authors:  Rita Sofia Garcia Ribeiro; Sarah Belderbos; Pierre Danhier; Juan Gallo; Bella B Manshian; Bernard Gallez; Manuel Bañobre; Marcel de Cuyper; Stefaan J Soenen; Willy Gsell; Uwe Himmelreich
Journal:  Int J Nanomedicine       Date:  2019-07-29

9.  Assessment of bystander killing-mediated therapy of malignant brain tumors using a multimodal imaging approach.

Authors:  Cindy Leten; Jesse Trekker; Tom Struys; Tom Dresselaers; Rik Gijsbers; Greetje Vande Velde; Ivo Lambrichts; Annemie Van Der Linden; Catherine M Verfaillie; Uwe Himmelreich
Journal:  Stem Cell Res Ther       Date:  2015-09-07       Impact factor: 6.832

10.  Monitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors.

Authors:  Cindy Leten; Jesse Trekker; Tom Struys; Valerie D Roobrouck; Tom Dresselaers; Greetje Vande Velde; Ivo Lambrichts; Catherine M Verfaillie; Uwe Himmelreich
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.